Morie A. Gertz, MD of Mayo Clinic discusses the new novel agents which might have significant therapeutic impact in multiple myeloma at the Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
Morie A. Gertz, MD of Mayo Clinic discusses the new novel agents which might have significant therapeutic impact in multiple myeloma at the Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.